Medical Union Pharmaceuticals
Ahmed Attia is an experienced professional in the pharmaceutical industry, currently serving as the Quality Assurance Manager and Acting Quality Control Manager at Medical Union Pharmaceuticals since April 2015. Prior to this role, Ahmed held various positions at Eli Lilly and Company from August 2009 to March 2015, including QC Chemistry Team Leader, Senior QC Analyst, and Quality Control Analyst. Ahmed's career began at Minapharm Pharmaceuticals, where responsibilities as a Downstream Specialist were undertaken from June 2006 to August 2009. Ahmed Attia holds a B.Sc. in Pharmacy from Cairo University, obtained between 1997 and 2002.
This person is not in any teams
Medical Union Pharmaceuticals
Owing to our integrity,honesty,fairness,respect,commitment and transparency, we have faced wide business competition over the past years; however we have introduced several corporate changes and new business management system, which resulted in noticeable position among the top pharmaceutical companies in the market and moreover getting transnational position in over 30 countries. Today, MUP have grown to be a regional key player due to our dedication to delivering the highest standards of quality and excellence in each and every line of business we operate in.We are ready to face further challenges in the highly competitive market, being confident to our value’s drivers and proud of our multiple achievements in relatively little time. MUP is one of the large pharmaceutical firms in Egypt. In strategic location, near the city Ismailia, Ain Sokhna port, Suez port, Portsaid port and Cairo Airport. MUP established a modern pharmaceutical manufacturing facility which incorporates many contemporary construction design features, raw materials handling, production concepts, a state-of-the-art manufacturing lines which rival the most modern American, European and Japanese counterparts. MUP as the first national pharmaceutical company in Egypt that acquires a multinational subsidiary and has successfully accomplished the acquisition of human insulin factory of Eli Lilly. MUP starts the production of the human insulin under our brand (Insulinagypt) MUP has successfully started the production in the Cephalosporin & Penicillin new factories MUP plans to be one of the top five leading international pharmaceutical manufacturers in Egypt, Africa, East Europe and the MENA region.